Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00279370 · ClinicalTrials.gov registry record
Antidepressant Use During Pregnancy
A clinical trial of Depression, sponsored by University of Pittsburgh.
- Completed
- Registry status
- 283
- Enrollment target
- 1
- Study location
NCT00279370: Completed study of Depression, sponsored by University of Pittsburgh.
NCT00279370 is a study of Depression that has completed, run by University of Pittsburgh. The registered enrollment target is 283 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00279370, a study of Depression, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- 283 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will determine the safety of antidepressant use during pregnancy for both the mother and the child.
Conditions Studied
Study Locations (1)
Pennsylvania
- Women's Behavioral HealthCARE Program - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 283 participants |
| Start Date | 1999-09 |
| Est. Completion | 2009-12 |
What the finished NCT00279370 record still lists
NCT00279370 is an observational study that tracks outcomes without assigning an intervention. The registered 283 participants enrollment target is mid-sized for trials with a published cap, below the 786-participant average among 679 other Depression trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Depression appearing as the primary indexed condition, and to 0 interventions.
NCT00279370 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00279370 about?
NCT00279370 is a clinical study titled "Antidepressant Use During Pregnancy". This study will determine the safety of antidepressant use during pregnancy for both the mother and the child.
What is the current status of trial NCT00279370?
This trial is currently completed. The enrollment target is 283 participants. The study started on 1999-09. Estimated completion is 2009-12.
What conditions does trial NCT00279370 study?
This clinical trial studies the following conditions: Depression.
Who is sponsoring clinical trial NCT00279370?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00279370 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00279370's enrollment target sits among peer trials
283 157th of 679 higher than 523 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
Depression and Driving
RECRUITING
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
RECRUITING · Phase 1
-
Sleep to Reduce Incident Depression Effectively in Peripartum
RECRUITING · Phase 2
-
PET Imaging of Cyclooxygenase in Participants With Major Depressive Disorder (MDD)
RECRUITING · Phase 1
-
Identifying and Treating Depression in the Orthopaedic Trauma Population
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06856694 · 283 participants · NA
RCT of NLP-Based Feedback for Improving SDM in Men With Localized Prostate Cancer
- NCT05263206 · 284 participants · Phase 3
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
- NCT05769218 · 284 participants · NA
PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study
- NCT06856577 · 284 participants · Phase 3
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-Related Macular Degeneration
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia